Jefferies Group Reaffirms “Buy” Rating for Udg Healthcare PLC (UDG)
Udg Healthcare PLC (LON:UDG)‘s stock had its “buy” rating reaffirmed by Jefferies Group in a research note issued on Monday. They currently have a GBX 400 ($6.69) price target on the stock. Jefferies Group’s price target would suggest a potential upside of 16.62% from the stock’s previous close.
Udg Healthcare PLC (LON:UDG) opened at 342.40 on Monday. Udg Healthcare PLC has a one year low of GBX 293.30 and a one year high of GBX 380.10. The stock’s 50-day moving average is GBX 347.8 and its 200-day moving average is GBX 351.3. The company’s market cap is £826.6 million.
UDG has been the subject of a number of other recent research reports. Analysts at Goodbody Stockbrokers Ltd reiterated a “buy” rating on shares of Udg Healthcare PLC in a research note on Monday. Separately, analysts at Davy Research reiterated an “outperform” rating on shares of Udg Healthcare PLC in a research note on Monday. Finally, analysts at Investec raised their price target on shares of Udg Healthcare PLC from GBX 360 ($6.02) to GBX 365 ($6.10) in a research note on Monday. They now have a “hold” rating on the stock. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company. Udg Healthcare PLC currently has a consensus rating of “Buy” and a consensus price target of GBX 381.25 ($6.37).
UDG Healthcare plc is an international provider of services to healthcare manufacturers and pharmaceutical retailers.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.